Electronic Drug Delivery Systems Market Report 2026

Electronic Drug Delivery Systems Market Overview

• Electronic Drug Delivery Systems market size has reached to $11.93 billion in 2025 • Expected to grow to $19.44 billion in 2030 at a compound annual growth rate (CAGR) of 10.4% • Growth Driver: Rising Prevalence Of Chronic Disease • Market Trend: Innovative Reusable Injector Platform Enhances Precision, Adherence, And Sustainability In Drug Delivery • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Electronic Drug Delivery Systems Market?

Electronic drug delivery systems refer to a type of device or formulation that can enable a medical substance to reach a selective region without reaching non-target cells and tissues. Electronic drug delivery systems are used to deliver a constant and regulated dose of drugs through easy monitoring of doses. The main types of electronic drug delivery systems are electronic infusion pumps, electronic injection pens, electronic auto-injectors, electronic inhalers, electronic capsules, and other types. Electronic infusion pumps refer to a type of medical device that can deliver fluids into a patient's body in controlled amounts. Electronic infusion pumps are used in healthcare settings such as hospitals and nursing homes to deliver fluids such as nutrients and medications into a patient's body. The various components of electronic drug delivery systems are sensors, wireless communicators and antennas, micro-pumps and flow regulators, drug reservoirs, microcontrollers, and other components that are available in battery-powered systems and rechargeable systems. The electronic drug delivery systems are distributed through hospital pharmacies, retail pharmacies, and online pharmacies that are suitable for the treatment of diabetes, cardiovascular disease, respiratory disorders, multiple sclerosis, and other diseases.

What Is The Electronic Drug Delivery Systems Market Growth Forecast?

The electronic drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $19.44 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing demand for personalized drug delivery, rising adoption of digital health ecosystems, expansion of remote patient monitoring, growing focus on adherence-driven outcomes, increasing integration of ai-based dosing algorithms. Major trends in the forecast period include increasing adoption of smart drug delivery devices, rising integration of connected and wearable delivery systems, growing use of precision dose control technologies, expansion of patient-centric self-administration devices, enhanced focus on therapy adherence monitoring.

Global Electronic Drug Delivery Systems Market Segmentation

1) By Type: Electronic Infusion Pumps, Electronic Injection Pens, Electronic Auto-Injectors, Electronic Inhalers, Electronic Capsules 2) By Component: Sensors, Wireless Communicator And Antennas, Micro Pumps And Flow Regulators, Drug Reservoir, Microcontroller, Other Components 3) By System Type: Battery-Powered Systems, Rechargeable Systems 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies 5) By Application: Diabetes, Cardiovascular Disease, Respiratory Disorders, Multiple Sclerosis, Other Applications Subsegments: 1) By Electronic Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps 2) By Electronic Injection Pens: Insulin Pens, Growth Hormone Pens, Other Injectable Medication Pens 3) By Electronic Auto-Injectors: Pre-filled Auto-Injectors, Spring-Loaded Auto-Injectors 4) By Electronic Inhalers: Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI), Soft Mist Inhalers 5) By Electronic Capsules: Smart Capsules, Digital Capsules With Sensors

What Is The Driver Of The Electronic Drug Delivery Systems Market?

The rising prevalence of chronic disease is expected to propel the growth of the electronic drug delivery systems market going forward. Chronic disease refers to a condition or disease that lasts for more than a year and requires ongoing medical treatment. Electronic drug delivery systems are used for regulating drug doses and make monitoring drug doses easy for people who suffer from chronic diseases. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older who have at least 1 chronic condition would increase to 142.66 million by 2050. Therefore, the rising prevalence of chronic diseases will drive the electronic delivery system market.

Key Players In The Global Electronic Drug Delivery Systems Market

Major companies operating in the electronic drug delivery systems market are Medtronic plc, Novo Nordisk A/S, Insulet Corporation, Tandem Diabetes Care Inc., United Therapeutics Corporation, Sanofi S.A., Abbott Laboratories, Roche Holding AG, Johnson & Johnson, Bayer AG, Antares Pharma Inc., CeQur Corporation, BIOCORP, Adherium Limited, Amiko Digital Health Limited, FindAir Sp. z o.o., HCmed Innovations Co. Ltd., Insulet International Limited, Ypsomed Holding AG, Enable Injections Inc., Eitan Medical Ltd.

Global Electronic Drug Delivery Systems Market Trends and Insights

Major companies in the electronic drug delivery systems market are focusing on innovative solutions, such as reusable electronic injector platforms, to enhance drug delivery precision, patient adherence, and sustainability. A reusable electronic injector platform is a battery-powered, smart injection device that can be used multiple times to deliver precise doses of medication while tracking usage and supporting patient adherence. For instance, in January 2025, Portal Instruments Inc., a US-based medical device company, launched PRIME Nexus, a new reusable electronic injector platform designed to improve the administration of injectable medications, with specific enhancements for precision, versatility, and sustainability in drug delivery. It supports multiple drug container sizes, including 1 mL and 2.25 mL pre-filled syringes and 3 mL cartridges, and can handle high-viscosity formulations up to 600 cP. The device offers programmable injection control and optional connectivity for adherence monitoring and data sharing with healthcare providers. Its reusable design promotes sustainability by reducing medical waste and lowering overall injection costs.

What Are Latest Mergers And Acquisitions In The Electronic Drug Delivery Systems Market?

In November 2025, Biogen Inc a US-based biotechnology company, acquired Alcyone Therapeutics for an undisclosed amount. With this acquisition, Biogen aims to enhance its central nervous system (CNS) drug delivery capabilities and expand its pipeline of targeted therapeutics. Alcyone Therapeutics Inc is a US-based healthcare technology company that specializes in developing advanced drug delivery platforms designed to improve precision and efficacy in treating neurological disorders.

Regional Outlook

North America was the largest region in the electronic drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global electronic drug delivery systems market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Electronic Drug Delivery Systems Market?

The electronic drug delivery systems market consists of sales of nasal sprays, eyedroppers, and intrauterine devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.